(Q41099769)

English

Usefulness of liver test and controlled attenuation parameter in detection of nonalcoholic fatty liver disease in patients with chronic renal failure and coronary heart disease.

scientific article published on 9 April 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25854911%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Usefulness of liver test and controlled attenuation parameter in detection of nonalcoholic fatty liver disease in patients with chronic renal failure and coronary heart disease (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25854911%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

fatty liver disease

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

Luka Zaputović

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25854911%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25854911%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Ivana Mikolasevic

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25854911%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Lidija Orlic

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25854911%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Sanjin Racki

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25854911%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Zlatko Cubranic

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25854911%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Kata Anic

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25854911%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Bosiljka Devcic

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25854911%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

9 April 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25854911%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Vienna Clinical Weekly

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25854911%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

127

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25854911%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

11-12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25854911%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

451-458

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25854911%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

https://scigraph.springernature.com/pub.10.1007/s00508-015-0757-z

0 references

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Nonalcoholic fatty liver disease (NAFLD): a new risk factor for adverse cardiovascular events in dialysis patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Non-alcoholic fatty liver disease and increased risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Relationship between non-alcoholic fatty liver disease and kidney function: a communication between two organs that needs further exploration

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Chronic kidney disease and nonalcoholic Fatty liver disease proven by transient elastography.

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Update of liver fibrosis and steatosis with transient elastography (Fibroscan).

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Liver enzymes in patients with chronic kidney disease undergoing peritoneal dialysis and hemodialysis

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Updated definitions of healthy ranges for serum alanine aminotransferase levels

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Oxidative stress in end-stage renal disease: an emerging threat to patient outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Risk factors associated with cardiovascular morbidity and mortality in Spanish incident hemodialysis patients: two-year results from the ANSWER study.

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Chronic kidney disease as cause of cardiovascular morbidity and mortality

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Metabolic syndrome in kidney transplantation: management of risk factors

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Prevention of cardiovascular disease in adult recipients of kidney transplants

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Outcome of patients hospitalized for complications after outpatient liver biopsy

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Getting closer to a point-of-care diagnostic assessment in patients with chronic liver disease: controlled attenuation parameter for steatosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population.

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Controlled attenuation parameter for noninvasive assessment of hepatic steatosis using Fibroscan®: validation in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal.

1 reference

https://api.crossref.org/works/10.1007%2FS00508-015-0757-Z

21 January 2018

[Metabolic disorders in renal transplant recipients]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25854911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/25854911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of cardiovascular risk in patients with chronic kidney disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25854911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pathogenesis of decreased aspartate aminotransferase and alanine aminotransferase activity in the plasma of hemodialysis patients: the role of vitamin B6 deficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/25854911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography

1 reference

https://pubmed.ncbi.nlm.nih.gov/25854911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/25854911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of hepatic steatosis using the controlled attenuation parameter: a comparative study with liver biopsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25854911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25854911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Noninvasive assessment of liver fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25854911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Noninvasive detection of hepatic steatosis in patients without ultrasonographic evidence of fatty liver using the controlled attenuation parameter evaluated with transient elastography

1 reference

https://pubmed.ncbi.nlm.nih.gov/25854911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00508-015-0757-Z

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25854911%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25854911%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41099769&oldid=2093481544"